A Fast-Growing, Global Innovator of
Bone and Joint Restoration Products
- Oct 22, 2013 Exactech Q3 Net Income up 25% to $3.2 Million. Diluted EPS $0.23 vs. $0.19. Worldwide Sales Up 9% to $55.7 Million. U.S. Sales Increased 11%
- Exactech's collaborative relationships with surgeons serve the interests of patients and meet high ethical standards. View our code of ethics, hotline, and details about our consultants here.